CAJ | 학술논문

目的：探讨影响外科手术切除的小细胞肺癌（SCLC）患者获得长期生存的因素。方法：对1957年至1992年底经外科手术切除的SCLC76例长期生存者进行综合分析。结果：全组TNM分期为：Ⅰa期8例（10．5％），Ⅰb期16例（21．1％）；Ⅱa期13例（17．1％），Ⅱb期9例（11．8％）；Ⅲa期29例（38．2％），Ⅲb期1例（1．3％）。其中综合治疗56例，单纯手术20例。综合治疗在各期中的百分比分别为Ⅰ期58．3％（14／24），Ⅱ期90．9％（20／22），Ⅲa期72．4％（21／29），Ⅲb期100％（1／1）。结论：TNM分期早，力争根治性切除，并采用综合治疗是SCLC长期生存病例的重要特点。TNM分期越晚，越应强调综合治疗。尽可能少输血及术中纵隔等部位淋巴结清扫有益于长期生存。
목적：탐토영향외과수술절제적소세포폐암（SCLC）환자획득장기생존적인소。방법：대1957년지1992년저경외과수술절제적SCLC76례장기생존자진행종합분석。결과：전조TNM분기위：Ⅰa기8례（10．5％），Ⅰb기16례（21．1％）；Ⅱa기13례（17．1％），Ⅱb기9례（11．8％）；Ⅲa기29례（38．2％），Ⅲb기1례（1．3％）。기중종합치료56례，단순수술20례。종합치료재각기중적백분비분별위Ⅰ기58．3％（14／24），Ⅱ기90．9％（20／22），Ⅲa기72．4％（21／29），Ⅲb기100％（1／1）。결론：TNM분기조，력쟁근치성절제，병채용종합치료시SCLC장기생존병례적중요특점。TNM분기월만，월응강조종합치료。진가능소수혈급술중종격등부위림파결청소유익우장기생존。
Objective： To explore the factors which relate to the long－termsurvival of the patients with small cell lung cancer (SCLC) after surgery． Methods： From January 1957 to December 1992, Senenty－six cases of SCLC who had long－term survival after surgery were retrospectively analysed． Results： According to TNM staging (1998), there were 24 (31．6％) cases of stage Ⅰ, 22(28．9％) stage Ⅱ, 29(38．2％) stage Ⅲa and one (1．3％) case of stage Ⅲb． Among these, 56 case received combined treatment, and 20 cases had operation only． The percentage of the combined treatment used in the various stages were as follows： stage Ⅰ 58．3％(14／24), stage Ⅱ 90．9％(20／22), stage Ⅲa 72．4％(21／29), stage Ⅲb 100％(1／1)． Conclusion： The early stage of TNM and radical resection with combined therapy are most importance in the treatment of SCLC and extensive hilar and mediastinal node resection is necessary to achieve long－term survival．